Clinical presentation, staging and long-term evolution of parathyroid cancer

Annals of Surgical Oncology

Volumn 17, Issue 8, 2010, Pages 2156-2174

  Talat, Nadia ^a,b   Schulte, Klaus Martin ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PARATHYROID CARCINOMA; SEX DIFFERENCE; SURGICAL TECHNIQUE; THYROID SURGERY; AGED; FOLLOW UP; MIDDLE AGED; MORTALITY; PARATHYROID TUMOR; PATHOLOGY; PROCEDURES; RISK FACTOR; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PARATHYROID NEOPLASMS; RISK FACTORS; SURVIVAL RATE;

EID: 77954951443     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1003-6     Document Type: Article

References (193)

1. Koea JB, Shaw JH. Parathyroid cancer: biology and management. Surg Oncol. 1999;8:155-65.
2. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg. 1991;15:738-44.
3. Howman-Giles R, Shaw PJ, Uren RF, Chung DK. Neuroblastoma and other neuroendocrine tumors. Semin Nucl Med. 2007;37:286-302.
4. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32:676-80.
5. Fakhran S, Branstetter BFt, Pryma DA. Parathyroid imaging. Neuroimaging Clin N Am. 2008;18:537-49, ix.
6. Holmes EC, Morton DL, Ketcham AS. Parathyroid carcinoma: a collective review. Ann Surg. 1969;169:631-40.
7. Okamoto T, Iihara M, Obara T, Tsukada T. Parathyroid Carcinoma: Etiology, Diagnosis, and Treatment. World J Surg. 2009;33:2343-54.
8. Mallette LE, Bilezikian JP, Heath DA, Aurbach GD. Primary hyperparathyroidism: clinical and biochemical features. Medicine (Baltimore) 1974;53:127-46.
9. Mittendorf EA, McHenry CR. Parathyroid carcinoma. J Surg Oncol. 2005;89:136-42.
10. Poissonnet G, Castillo L, Bozec A, Peyrottes I, Ettore F, Santini J, et al. Parathyroid carcinoma. Bull Cancer. 2006;93:283-7.
11. Rodgers SE, Perrier ND. Parathyroid carcinoma. Curr Opin Oncol. 2006;18:16-22.
12. Rawat N, Khetan N, Williams DW, Baxter JN. Parathyroid carcinoma. Br J Surg. 2005;92:1345-53.
13. DeLellis RA. Parathyroid carcinoma-An overview. Adv Anat Pathol. 2005;12:53-61.
14. Rao SR, Shaha AR, Singh B, Rinaldo A, Ferlito A. Management of cancer of the parathyroid. Acta Otolaryngol. 2002;122:448-52.
15. Bossola M, Tazza L, Ferrante A, Giungi S, Carbone A, Gui D, et al. Parathyroid carcinoma in a chronic hemodialysis patient: case report and review of the literature. Tumori. 2005;91:558-62.
16. Boyle NH, Ogg CS, Hartley RB, Owen WJ. Parathyroid carcinoma secondary to prolonged hyperplasia in chronic renal failure and in coeliac disease. Eur J Surg Oncol. 1999;25:100-3.
17. Djema AI, Mahmoud MD, Collin P, Heymann MF. [Tertiary hyperparathyroidism: parathyroid cancer with liver metastases in a hemodialyzed patient]. Nephrologie. 1998;19:121-3.
18. Jayawardene S, Owen WJ, Goldsmith DJ. Parathyroid carcinoma in a dialysis patient. Am J Kidney Dis. 2000;36: E26.
19. Jimenez-Garcia A, Milan JA, Garcia-Escudero A, Marín-Velarde C, Cantillana J, Echenique-Elizondo M. Parathyroid carcinoma on transplanted parathyroid tissue after total parathyroidectomy for renal hyperparathyroidism. Am J Clin Oncol. 2006;29:207-8.
20. Khan MW, Worcester EM, Straus FH, 2nd, Khan S, Staszak V, Kaplan EL. Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg. 2004;199:312-9.
21. Miki H, Sumitomo M, Inoue H, Kita S, Monden Y. Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis. Surgery. 1996;120:897-901.
22. Pineda E, Perez-Ordonez B, Dackiw A, Jassal SV. Parathyroid carcinoma should be suspected in dialysis patients with rapid changes in serum parathormone levels. Perit Dial Int. 2005;25:93-4.
23. Rademaker P, Meijer S, Oosterhuis JW, Vermey A, Zwierstra R, vd Hem G, et al. Successful surgical treatment of parathyroid carcinoma in two haemodialysis patients. Nephrol Dial Transplant. 1990;5:545-8.
24. Srouji IA, Resouly A, Cree IA. Case of thymic parathyroid carcinoma in a haemodialysis patient: application of tumour chemosensitivity testing. J Laryngol Otol. 2004;118:162-4.
25. Takami H, Kameyama K, Nagakubo I. Parathyroid carcinoma in a patient receiving long-term hemodialysis. Surgery. 1999;125:239-40.
26. Tkaczyk M, Czupryniak A, Nowicki M. Ectopic mediastinal parathyroid carcinoma as a cause of dialysis-dependent renal failure. Hemodial Int. 2007;11:398-402.
27. Tominaga Y, Numano M, Uchida K, Sato K, Asano H, Haba T, et al. Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient: report of a case. Surg Today. 1995;25:984-6.
28. Tseng CC, Huang JJ, Wang MC, Lan RR, Sung JM, Chen FF. Parathyroid carcinoma with multiple lung metastases. Nephrol Dial Transplant. 1999;14:449-51.
29. Geier A, Furst H, Laubach E, Stabler A, Riling R, Muller-Hocker J, et al. [Somnolence and vomiting in a patient after parathyroid gland carcinoma surgery]. Internist (Berl). 1999;40:311-5.
30. Gittler RD, Maier H. Carcinoma of the parathyroid. Arch Intern Med. 1972;130:413-7.
31. Gray JH, Castillo F, Vasinrapee P. Multifocal parathyroid carcinoma in subtotal thyroidectomy. Clin Nucl Med. 2000;25:917-8.
32. Haghighi P, Astarita RW, Wepsic HT, Wolf PL. Concurrent primary parathyroid hyperplasia and parathyroid carcinoma. Arch Pathol Lab Med. 1983;107:349-50.
33. Hirschel-Scholz S, Jung A, Fischer JA, Trechsel U, Bonjour JP. Suppression of parathyroid secretion after administration of WR-2721 in a patient with parathyroid carcinoma. Clin Endocrinol (Oxf). 1985;23:313-8.
34. Holch P, Forray M, Emmermann A, Schroder S, Zornig C. [Parathyroid gland carcinoma with postoperative encephalopathy]. Chirurg. 2000;71:1489-92.
35. Kelly TR. Parathyroid carcinoma: a case report and review of the literature. Am Surg. 1969;35:374-6.
36. Kirstein LJ, Ghosh BC. Intrathyroid parathyroid carcinoma. J Surg Oncol. 2001;77:136-8.
37. Kitapci MT, Tastekin G, Turgut M, Caner B, Kars A, Barista I, et al. Preoperative localization of parathyroid carcinoma using Tc-99 m MIBI. Clin Nucl Med. 1993;18:217-9.
38. Mansour KA, Letton AH. Adenocarcinoma of the parathyroid gland: review of the literature and report of one case. Am Surg. 1967;33:378-81.
39. Pai M, Park CH, Kim BS, Chung YS, Park HB. Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease. Clin Nucl Med. 1997;22:691-4.
40. Rossi P, Carillo FJ, Johnston B. Angiography in the diagnosis of parathyroid carcinoma. N Engl J Med. 1971;284:198-201.
41. Sherif M, el-Bolkainy N, Khattar N. Carcinoma of the parathyroid gland. A case report and review of literature. J Egypt Med Assoc. 1970;53:71-8.
42. Singer FR, Neer RM, Murray TM, Keutmann HT, Deftos LJ, Potts JT Jr. Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma. N Engl J Med. 1970;283:634-6.
43. Singhal T, Jacobs M, Mantil JC. Tc-99 m pertechnetate/sestamibi subtraction scan in a case of parathyroid carcinoma. Clin Nucl Med. 2008;33:196-7.
44. Ahmad F, Strickland AD, Wright GM, Elabassy M, Kiruparan P, Bell PR, et al. Laparoscopic microwave tissue ablation of hepatic metastasis from a parathyroid carcinoma. Eur J Surg Oncol. 2005;31:321-2.
45. Bukowski RM, Sheeler L, Cunningham J, Esselstyn C. Successful combination chemotherapy for metastatic parathyroid carcinoma. Arch Intern Med. 1984;144:399-400.
46. Guazzi A, Gabrielli M, Guadagni G. Cytologic features of a functioning parathyroid carcinoma: a case report. Acta Cytol. 1982;26:709-13.
47. Lee YT, Hutcheson JK. Mediastinal parathyroid carcinoma detected on routine chest films. Chest. 1974;65:354-5.
48. Love GL, Samuels M. Fatal acute hyperparathyroidism and parathyroid carcinoma. South Med J. 1983;76:407-8.
49. Pak CY, Wills MR, Smith GW, 2nd, Bartter FC. Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma. J Clin Endocrinol Metab. 1968;28:1657-60.
50. Sato K, Toraya S, Shiratori K, Kasagi Y, Mandai Y, Miyamoto T, et al. Appropriate intravenous doses of L-thyroxine and magnesium in a thyroidectomized patient with thyroid and parathyroid carcinomas receiving total parenteral nutrition during acute necrotizing pancreatitis. Intern Med. 1995;34:176-82.
51. Smith JF, Coombs RR. Histological diagnosis of carcinoma of the parathyroid gland. J Clin Pathol. 1984;37:1370-8.
52. Szmuilowicz ED, Utiger RD. A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy. Nat Clin Pract Endocrinol Metab. 2006;2:291-6; quiz 297.
53. Bergero N, De Pompa R, Sacerdote C, Gasparri G, Volante M, Bussolati G, et al. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol. 2005;36:908-14.
54. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet. 2003;40:657-63.
55. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349:1722-9.
56. Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, et al. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab. 2004;89:5583-91.
57. Haven CJ, van Puijenbroek M, Tan MH, Teh BT, Fleuren GJ, van Wezel T, et al. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Clin Endocrinol (Oxf). 2007;67:370-6.
58. Vega EM, Mautalen CA. Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma. Medicina (B Aires). 1991;51:106-10.
59. Newrick PG, Braatvedt GD, Webb AJ, Sheffield E, Corrall RJ. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate. Postgrad Med J. 1994;70:231-2.
60. Warrell RP, Jr., Issacs M, Alcock NW, Bockman RS. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma. Ann Intern Med. 1987;107:683-6.
61. Schott M, Feldkamp J, Schattenberg D, Krueger T, Dotzenrath C, Seissler J, et al. Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells. Eur J Endocrinol. 2000;142:300-6.
62. Bradwell AR, Harvey TC. Control of hypercalcaemia of parathyroid carcinoma by immunisation. Lancet. 1999;353:370-3.
63. Betea D, Bradwell AR, Harvey TC, Mead GP, Schmidt-Gayk H, Ghaye B, et al. Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma. J Clin Endocrinol Metab. 2004;89:3413-20.
64. Bondeson L, Sandelin K, Grimelius L. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol. 1993;17:820-9.
65. Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, et al. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol. 2006;30:1140-9.
66. Gimm O, Lorenz K, Thanh PN, Schneyer U, Bloching M, Howell VM, et al. Prophylactic parathyroidectomy for familial parathyroid carcinoma. Chirurg. 2006;77:15-24.
67. Ikeda K, Tate G, Suzuki T, Mitsuya T. Cytologic comparison of a primary parathyroid cancer and its metastatic lesions: A case report. Diagn Cytopathol. 2006;34:50-5.
68. Ireland JP, Fleming SJ, Levison DA, Cattell WR, Baker LR. Parathyroid carcinoma associated with chronic renal failure and previous radiotherapy to the neck. J Clin Pathol. 1985;38:1114-8.
69. Johnson SJ, Sheffield EA, McNicol AM. Examination of parathyroid gland specimens. J Clin Pathol. 2005;58:338-42.
70. Montenegro F L D, Chammas MC, Juliano AG, Cernea CR, Cordeiro AC. Ethanol injection under ultrasound guidance to palliate unresectable parathyroid carcinoma. Arq Bras Endocrinol Metab. 2008;52:707-11.
71. Obara T, Fujimoto Y, Hirayama A, Kanaji Y, Ito Y, Kodama T, et al. Flow cytometric DNA analysis of parathyroid tumors with special reference to its diagnostic and prognostic value in parathyroid carcinoma. Cancer. 1990;65:1789-93.
72. Stojadinovic A, Hoos A, Nissan A, Dudas ME, Cordon-Cardo C, Shaha AR, et al. Parathyroid neoplasms: Clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol. 2003;34:54-64.
73. Szende B, Farid P, Vegso G, Perner F, Kopper L. Apoptosis and p53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Path Oncol Res. 2004;10:98-103.
74. Valdivielso P, Lopez-Sanchez J, Garrido A, Sanchez-Carrillo JJ. Metastatic calcifications and severe hypercalcemia in a patient with parathyroid carcinoma. J Endocrinol Invest. 2006;29:641-4.
75. Fuster D, Torregrosa JV, Esteve V, Ybarra J, Sabater L, AlósL, et al. [Parathyroid carcinoma associated to secondary hyper-parathyroidism in hemodialyzed patients. Two cases reports]. Nefrologia. 2007;27:209-13.
76. Collins FD, Warren MC, Palmer FJ, Rankin DR. Nonfunctioning parathyroid carcinoma: a case history. J Surg Oncol. 1986;31:60-1.
77. Mazeh H, Prus D, Freund HR. Incidental non-functional parathyroid carcinoma identified during thyroidectomy. Isr Med Assoc J. 2008;10:659.
78. Favia G. [Up-date on parotid gland surgery]. Ann Ital Chir. 2003;74:379-80.
79. Sandelin K, Tullgren O, Farnebo LO. Clinical course of metastatic parathyroid cancer. World J Surg. 1994;18:594-8; discussion 599.
80. van Heerden JA, Weiland LH, ReMine WH, Walls JT, Purnell DC. Cancer of the parathyroid glands. Arch Surg. 1979;114:475-80.
81. Aldinger KA, Hickey RC, Ibanez ML, Samaan NA. Parathyroid carcinoma: a clinical study of seven cases of functioning and two cases of nonfunctioning parathyroid cancer. Cancer. 1982;49:388-97.
82. Abrahams TG, Hanks P, Jones M. Hyperfunctioning parathyroid carcinoma. Skeletal Radiol. 2000;29:112-5.
83. Al-Sobhi S, Shira H, Al-Dayel F, Ahmed M, Ingemansson S. Parathyroid carcinoma: A report of two cases. Ann Saudi Med. 1999;19:431-3.
84. Anderson BJ, Samaan NA, Vassilopoulou-Sellin R, Ordonez NG, Hickey RC.: Parathyroid carcinoma: features and difficulties in diagnosis and management. Surgery. 1983;94:906-15.
85. Artinyan A, Guzman E, Maghami E, Al-Sayed M, D'Apuzzo M, Wagman L, et al. Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization. J Clin Oncol. 2008;26:4039-41.
86. Aso Y, Sato A, Tayama K, Takanashi K, Satoh H, Takemura Y. Parathyroid carcinoma with metastatic calcification identified by technetium-99 m methylene diphosphonate scintigraphy. Intern Med. 1996;35:392-5.
87. Au WY. Calcitonin treatment of hypercalcemia due to parathyroid carcinoma. Synergistic effect of prednisone on longterm treatment of hypercalcemia. Arch Intern Med. 1975;135:1594-7.
88. Bhansali A, Kataria RN, Dutta P, Saha MM, Singh P, Dash RJ. Parathyroid carcinoma: difficult management options. Indian J Cancer. 2002;39:119-22.
89. Brown JJ, Mohamed H, Williams-Smith L, Osborne R, Coker J, Yee B. Primary hyperparathyroidism secondary to simultaneous bilateral parathyroid carcinoma. Ear Nose Throat J. 2002;81:395-8, 400-1.
90. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716-26.
91. Calandra D, Shah K, Lawrence AM, Paloyan E. Parathyroid carcinoma. A report of five cases. Am Surg. 1985;51:372-4.
92. Caley JP, Jones EE, Collins DH. Fatal recurrence of parathyroid carcinoma after seven years. J Clin Pathol. 1962;15:438-45.
93. Cheah WK, Rauff A, Lee KO, Tan W. Parathyroid carcinoma: a case series. Ann Acad Med Singapore. 2005;34:443-6.
94. Chow E, Tsang RW, Brierley JD, Filice S. Parathyroid carcinoma-the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys. 1998;41:569-72.
95. Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer. 2004;100:900-5.
96. Cohn K, Silverman M, Corrado J, Sedgewick C. Parathyroid carcinoma: the Lahey Clinic experience. Surgery. 1985;98:1095-100.
97. Crescenzo DG, Shabahang M, Garvin D, Evans SR. Intrathyroidal parathyroid cancer presenting as a left neck mass. Thyroid. 1998;8:597-9.
98. de la Garza S, Flores de la Garza E, Hernandez Batres F. Functional parathyroid carcinoma. Cytology, histology, and ultrastructure of a case. Diagn Cytopathol. 1985;1:232-5.
99. de Papp AE, Kinder B, LiVolsi V, Gupta SM, Stewart AF. Parathyroid carcinoma arising from parathyroid hyperplasia: autoinfarction following intravenous treatment with pamidro-nate. Am J Med. 1994;97:399-400.
100. Demirjian AN, Grossman JM, Chan JL, Parangi S. Parathyroid carcinoma and neurofibromatosis. Surgery. 2008;144:827-9.
101. Desch CE, Arsensis G, Woolf PD, May AG, Amatruda JM. Parathyroid hyperplasia and carcinoma within one gland. Am J Med. 1984;77:131-4.
102. Dotzenrath C, Goretzki PE, Sarbia M, Cupisti K, Feldkamp J, Röher HD. Parathyroid carcinoma: problems in diagnosis and the need for radical surgery even in recurrent disease. Eur J Surg Oncol. 2001;27:383-9.
103. Dubost C, Jehanno C, Lavergne A, Le Charpentier Y. Successful resection of intrathoracic metastases from two patients with parathyroid carcinoma. World J Surg. 1984;8:547-51.
104. Ellis HA, Floyd M, Herbert FK. Recurrent hyperparathyroidism due to parathyroid carcinoma. J Clin Pathol. 1971;24:596-604.
105. Eurelings M, Frijns CJ, Jeurissen FJ. Painful ophthalmoplegia from metastatic nonproducing parathyroid carcinoma: case study and review of the literature. Neuro Oncol. 2002;4:44-8.
106. Flye MW, Brennan MF. Surgical resection of metastatic parathyroid carcinoma. Ann Surg. 1981;193:425-35.
107. Fujimoto Y, Obara T, Ito Y, Kanazawa K, Aiyoshi Y, Nobori M. Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection. World J Surg. 1984;8:392-400.
108. Fujimoto Y, Obara T, Ito Y, Kodama T, Nobori M, Ebihara S. Localization and surgical resection of metastatic parathyroid carcinoma. World J Surg. 1986;10:539-47.
109. Gale TC, Owens CW. Hyperfunctioning carcinoma of the parathyroid gland. Postgrad Med J. 1972;48:626-31.
110. Gogas J, Kalos A, Skalkeas G. Functioning metastatic parathyroid carcinoma. Am Surg. 1975;41:419-21.
111. Gottswinter JM, Ziegler R, Weise HJ, Baczako K, Heymer B, Herfarth C. [Parathyroid carcinoma]. Klin Wochenschr. 1984;62:613-20.
112. Grodski S, Serpell J. Evidence for the role of perioperative PTH measurement after total thyroidectomy as a predictor of hypocalcemia. World J Surg. 2008;32:1367-73.
113. Hara H, Oyama T, Kimura M, Ishii E, Chiba S, Takasou K, et al. Cytologic characteristics of parathyroid carcinoma: a case report. Diagn Cytopathol. 1998;18:192-8.
114. Harris NL. Case records of the Massachusetts General Hospital-continuing to learn from the patient. N Engl J Med. 2003;348:2252-4.
115. Iacobone M, Lumachi F, Favia G. Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol. 2004;88:223-8.
116. Iihara M, Okamoto T, Suzuki R, Kawamata A, Nishikawa T, Kobayashi M, et al. Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis. Surgery. 2007;142:936-43; discussion 943.
117. Ito Y, Iwase H, Tanaka H, Yuasa H, Kureyama Y, Yamashita H, et al. Metachronous primary hyperparathyroidism due to a parathyroid adenoma and a subsequent carcinoma: report of a case. Surg Today. 2001;31:895-8.
118. Iwata T, Inoue K, Morita R, Mizuguchi S, Tsukioka T, Onoda N, et al. Functional large parathyroid carcinoma extending into the superior mediastinum. Ann Thorac Cardiovasc Surg. 2008;14:112-5.
119. Jarman WT, Myers RT, Marshall RB. Carcinoma of the parathyroid. Arch Surg. 1978;113:123-5.
120. Kameyama K, Takami H. Double parathyroid carcinoma. Endocr J. 2003;50:477-9.
121. Kirkby-Bott J, Lewis P, Harmer CL, Smellie WJ. One stage treatment of parathyroid cancer. Eur J Surg Oncol. 2005;31:78-83.
122. Kleinpeter KP, Lovato JF, Clark PB, Wooldridge T, Norman ES, Bergman S, et al. Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol. 2005;12:260-6.
123. Koyano H, Shishiba Y, Shimizu T, Suzuki N, Nakazawa H, Tachibana S, et al. Successful treatment by surgical removal of bone metastasis producing PTH: new approach to the management of metastatic parathyroid carcinoma. Intern Med. 1994;33:697-702.
124. Larmi TK, Kairaluoma MI, Huttunen R, Mokka R, Rasanen. Parathyroid carcinoma. A case report. Acta Chir Scand. 1976;142:471-4.
125. Lillemoe KD, Dudley NE. Parathyroid carcinoma: pointers to successful management. Ann R Coll Surg Engl. 1985;67:222-4.
126. Mann K. Oral biphosphonate therapy in metastatic parathyroid carcinoma. Lancet. 1985;1:101-2.
127. Mashburn MA, Chonkich GD, Chase DR, Petti GH, Jr. Parathyroid carcinoma: two new cases-diagnosis, therapy, and treatment. Laryngoscope. 1987;97:215-8.
128. Masson EA, MacFarlane IA, Bodmer CW, Vaughan ED. Parathyroid carcinoma presenting with a brown tumour of the mandible in a young man. Br J Oral Maxillofac Surg. 1993;31:117-9.
129. McGarity WC, Boehm G. Carcinoma of the parathyroid. South Med J. 1975;68:166-8.
130. McKeown PP, McGarity WC, Sewell CW. Carcinoma of the parathyroid gland: is it overdiagnosed? A report of three cases. Am J Surg. 1984;147:292-8.
131. Mezhir JJ, Melis M, Headley RC, Pai RK, Posner MC, Kaplan EL. Successful palliation of hypercalcemia secondary to meta-static parathyroid cancer: an unusual indication for hepatic resection. J Hepatobiliary Pancreat Surg. 2007;14:410-3.
132. Montenegro FL. [On carcinoma of the parathyroid gland]. Arq Bras Endocrinol Metabol. 2006;50:571; author reply 572.
133. Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS, et al.: Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer. 2003;98:2378-84.
134. Neumann DR, Esselstyn CB, Kim EY. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings. J Nucl Med. 1996;37:2000-1.
135. Nijs AM, Lether B, Misere JF, Lockefeer JH. A case of hyperparathyroidism caused by a parathyroid carcinoma. Case report and review of literature. Neth J Med. 1977;20:71-7.
136. Obara T, Okamoto T, Ito Y, Yamashita T, Kawano M, Nishi T, et al. Surgical and medical management of patients with pulmonary metastasis from parathyroid carcinoma. Surgery. 1993;114:1040-8; discussion 1048-9.
137. Ou HY, Hung CJ, Hsu WH, Yu EH, Wu TJ. Variability of clinical presentations in three cases of parathyroid carcinoma. J Formos Med Assoc. 2003;102:266-9.
138. Pahlavan PS, Severin MC. Parathyroid carcinoma: A rare case with mandibular brown tumor. Wien Klin Wochenschr. 2006;118:175-9.
139. Pai SI, Goldstein BJ, Studeman KD, Westra WH, Tufano RP. Concurrent sporadic parathyroid adenoma and carcinoma. Am J Otolaryngol. 2006;27:346-8.
140. Placzkowski K, Christian R, Chen H. Radioguided parathyroidectomy for recurrent parathyroid cancer. Clin Nucl Med. 2007;32:358-60.
141. Pollack S, Goldin RR, Cohen M. Parathyroid carcinoma. A report of two cases and a review of the literature. Arch Intern Med. 1961;108:583-7.
142. Qvist N, Kroll L, Ladefoged C, Blichert-Toft M, Rohr N. Parathyroid carcinoma: a case with recurrence treated with extensive vascular surgery to the neck. Eur J Surg Oncol. 1986;12:187-91.
143. Rasmuson T, Kristoffersson A, Boquist L. Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma. Eur J Endocrinol. 2000;143:749-54.
144. Robert JH, Trombetti A, Garcia A, Pache JC, Herrmann F, Spiliopoulos A, et al. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature. Ann Surg Oncol. 2005;12:526-32.
145. Sahasranam P, Tran MT, Mohamed H, Friedman TC. Multi-glandular parathyroid carcinoma: a case report and brief review. South Med J. 2007;100:841-4.
146. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16:724-31.
147. Saunders KB, Richardson J. Carcinoma of the parathyroid. Proc R Soc Med. 1970;63:453-4.
148. Schoretsanitis G, Melissas J, Kafousi M, Karkavitsas N, Tsiftsis DD. Synchronous parathyroid and papillary thyroid carcinoma: a case report. Am J Otolaryngol. 2002;23:382-5.
149. Severin MC, Jonas T. Parathyroid carcinoma. Isr Med Assoc J. 2003;5:604.
150. Shapiro DM, Recant W, Hemmati M, Mazzone T, Evans RH. Synchronous occurrence of parathyroid carcinoma and adenoma in an elderly woman. Surgery. 1989;106:929-33.
151. Sheehan JJ, Hill AD, Walsh MF, Crotty TB, McDermott EW, O'Higgins NJ. Parathyroid carcinoma: diagnosis and management. Eur J Surg Oncol. 2001;27:321-4.
152. Sinha S, Sinha A, McPherson GA. Synchronous sporadic carcinoma and primary hyperplasia of the parathyroid glands: A case report and review of the literature. Int J Surg Pathol. 2006;14:336-9.
153. Solorzano CC, Carneiro-Pla DM, Lew JI, Rodgers SE, Montano R, Irvin GL 3rd. Intra-operative parathyroid hormone monitoring in patients with parathyroid cancer. Ann Surg Oncol. 2007;14:3216-22.
154. Sulak LE, Brown RW, Butler DB. Parathyroid carcinoma with occult bone metastases diagnosed by fine needle aspiration cytology. Acta Cytol. 1989;33:645-8.
155. Tamura G, Miyoshi H, Ogata SY, Sasou S, Kudoh S, Kikuchi J, et al. Parathyroid carcinoma with anaplastic feature: association of a p53 gene mutation with anaplastic transformation. Pathol Int. 2009;59:107-10.
156. Tan GC, Shiran MS, Swaminathan M, Phang KS, Rohaizak M. Large retrosternal parathyroid carcinoma with primary hyper-parathyroidism. Asian J Surg. 2007;30:286-9.
157. Thomas RJ, Bowling T, Cassoni AM, Sagar SM. Metastatic parathyroid carcinoma: a radiological, biochemical and symptomatic response to metastectomy. J R Soc Med. 1992;85:182.
158. Tyler D, 3rd, Mandybur G, Dhillon G, Fratkin J. Intracranial metastatic parathyroid carcinoma: case report. Neurosurgery. 2001;48:937-9; discussion 939-40.
159. Vetto JT, Brennan MF, Woodruf J, Burt M. Parathyroid carcinoma: diagnosis and clinical history. Surgery. 1993;114:882-92.
160. Vikram HR, Petito A, Bower BF, Goldberg MH. Parathyroid carcinoma diagnosed on the basis of a giant cell lesion of the maxilla. J Oral Maxillofac Surg. 2000;58:567-9.
161. Wiseman SM, Rigual NR, Hicks WL, Jr., Popat SR, Lore JM Jr, Douglas WG, et al. Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J. 2004;83:491-4.
162. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore). 1992;71:197-205.
163. Yoshida S. Intracranial metastatic parathyroid carcinoma: case report. Surg Neurol. 2006;65:81-3.
164. Zisman E, Buckle RM, Deftos LJ, Aurbach GD, Morton DL, Bartter FC, et al. Production of parathyroid hormone by meta-static parathyroid carcinoma. Am J Med. 1968;45:619-23.
165. Barnes BA, Cope O. Carcinoma of the parathyroid glands, Report of 10 cases with endocrine function. JAMA. 1961;178:556-9.
166. Davies DR, Dent CE, Ives DR. Successful removal of single metastasis in recurrent parathyroid carcinoma. Br Med J. 1973;1:397-8.
167. Ehrlich A, Mc DJ, Zitani A, Jr. Carcinoma of the parathyroid with hyperparathyroidism and metastases. JAMA. 1961;176:453-5.
168. Gedik GK, Aksoy T, Bozkurt F, Ugur O, Caner B. Gamma probe-guided parathyroid cancer resection. Endocrinologist. 2008;18:71-2.
169. Iacobone M, Ruffolo C, Lumachi F, Favia G. Results of iterative surgery for persistent and recurrent parathyroid carcinoma. In: First Meeting of the European-Society-of-Endocrine-Surgery (ESES), Pisa, Italy, 2004:385-90.
170. Kern M, Lee G, Robbins P, Bynevelt M, Watson P. Intracranial metastatic parathyroid carcinoma-Case report and review of the literature. J Neurosurg. 2004;101:1065-9.
171. Lazar AW, Landau RL, Kappas A. Metastatic carcinoma of parathyroid and persistent hyperparathyroidism. Arch Pathol. 1961;72:484-9.
172. Rufener JB, Cohen JI. Metachronous spread of parathyroid carcinoma to a retropharyngeal lymph node. Head Neck. 2003;25:968-71.
173. Rios L, Sapunar J, Roa I. Primary hyperparathyroidism with severe skeletal involvement in one patient with parathyroid carcinoma. Rev Med de Chile. 2005;133:77-81.
174. Grayzel EF. Hyperparathyroidism in a patient with parathyroid carcinoma-15-year follow-up. Arch Intern Med. 1967;120:349-52.
175. Robbins KT. Classification of neck dissection: current concepts and future considerations. Otolaryngol Clin North Am. 1998;31:639-55.
176. Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86:378-80.
177. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U. S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86:538-44.
178. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109:1736-41.
179. Agarwal G, Prasad KK, Kar DK, Krishnani N, Pandey R, Mishra SK. Indian primary hyperparathyroidism patients with parathyroid carcinoma do not differ in clinicoinvestigative characteristics from those with benign parathyroid pathology. World J Surg. 2006;30:732-42.
180. Ippolito G, Palazzo FF, Sebag F, De Micco C, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg. 2007;94:566-70.
181. Wang CA, Gaz RD. Natural history of parathyroid carcinoma. Diagnosis, treatment, and results. Am J Surg. 1985;149:522-7.
182. Mucci-Hennekinne S, Desolneux G, Luyckx F, Gibelin H, Mirallie E, De Calan L, et al. [Parathyroid carcinoma: multi-center study of 17 patients]. J Chir (Paris). 2008;145:133-7.
183. Fernandez-Ranvier GG, Khanafshar E, Jensen K, Zarnegar R, Lee J, Kebebew E, et al. Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer. 2007;110:255-64.
184. Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001;136:878-85.
185. Cordeiro AC, Montenegro FL, Kulcsar MA, Dellanegra LA, Tavares MR, Michaluart P Jr, et al. Parathyroid carcinoma. Am J Surg. 1998;175:52-5.
186. Priya G, Jyotsna VP, Gupta N, Chumber S, Bal CS, Karak AK, et al. Clinical and laboratory profile of primary hyperparathyroidism in India. Postgrad Med J. 2008;84:34-9.
187. Falvo L, Catania A, D'Andrea V, Marzullo A, Giustiniani MC, De Antoni E. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg. 2005;241:640-6.
188. Gulcelik MA, Gulcelik NE, Kuru B, Camlibel M, Alagol H. Prognostic factors determining survival in differentiated thyroid cancer. J Surg Oncol. 2007;96:598-604.
189. Lo CY, Chan WF, Lam KY, Wan KY. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg. 2005;242:708-15.
190. D'Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, et al. Follicular thyroid carcinoma: histology and prognosis. Cancer. 2004;100:1123-9.
191. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1991;66:11-22.
192. Salmenkivi K, Heikkila P, Haglund C, Arola J. Malignancy in pheochromocytomas. APMIS. 2004;112:551-9.
193. Rodgers SE, Perrier ND. Parathyroid carcinoma. Curr Opin Oncol. 2006;18:16-22.